Ny, Lars
Jespersen, Henrik http://orcid.org/0000-0002-6543-5369
Karlsson, Joakim
Alsén, Samuel
Filges, Stefan http://orcid.org/0000-0002-5994-6699
All-Eriksson, Charlotta
Andersson, Bengt
Carneiro, Ana
Helgadottir, Hildur
Levin, Max
Ljuslinder, Ingrid
Olofsson Bagge, Roger
Sah, Vasu R.
Stierner, Ulrika
Ståhlberg, Anders http://orcid.org/0000-0003-4243-0191
Ullenhag, Gustav
Nilsson, Lisa M.
Nilsson, Jonas A. http://orcid.org/0000-0003-0346-6837
Funding for this research was provided by:
Merck
Knut och Alice Wallenbergs Stiftelse
Cancerfonden
Vetenskapsrådet
Familjen Erling-Perssons Stiftelse
Article History
Received: 28 March 2021
Accepted: 5 August 2021
First Online: 27 August 2021
Competing interests
: Lars Ny received a research grant from MSD and Syndax Pharmaceuticals to support some aspects of the PEMDAC study. Anders Ståhlberg is the coinventor of SiMSen-Seq (ctDNA measurement), is a board member of, and has stock ownership in SiMSen Diagnostics. The remaining authors declare no conflict of interest.